Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcus Q Bernardini

Showing results (21-30 of 126) with videos related to

Pageof 13
Sort By:
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 21, 2012
Prognostic and predictive value of CA-125 in the primary treatment of epithelial ovarian cancer: potentials and pitfallsIván Díaz-Padilla, Albiruni Ryan Abdul Razak, Lucas Minig, et al.
Journal of Surgical Oncology|November 24, 2025
Treatment Strategy and Residual Disease as Determinants of Survival in Stage IVB High-Grade Serous Ovarian Cancer: A Retrospective Cohort StudyAnouk Benseler, Adina Tanen, Taymaa May, et al.
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC|May 11, 2013
A triage assessment strategy for the management of women with endometrial cancerLuc R C W van Lonkhuijzen, Barry P Rosen, Stephanie Bertin, et al.
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC|January 7, 2021
Does Radical Hysterectomy for Clinically Apparent Stage II Endometrial Cancer Affect Risk of Local Recurrence?Genevieve K Lennox, Mitchell Clark, Tiffany Zigras, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 2011
Phenotypic heterogeneity and instability of human ovarian tumor-initiating cellsJocelyn M Stewart, Patricia A Shaw, Craig Gedye, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|November 3, 2017
The prognostic value of perioperative, pre-systemic therapy CA125 levels in patients with high-grade serous ovarian cancerTaymaa May, Jocelyn M Stewart, Marcus Q Bernardini, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 29, 2022
Oncologic and pregnancy outcomes after fertility-sparing surgery for stage I, low-grade endometrioid ovarian cancerBrenna E Swift, Allan Covens, Victoria Mintsopoulos, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 31, 2021
The effect of complete surgical staging and adjuvant chemotherapy on survival in stage I, grade 1 and 2 endometrioid ovarian carcinomaBrenna E Swift, Allan Covens, Victoria Mintsopoulos, et al.
Gynecologic Oncology|August 2, 2017
Is adjuvant chemotherapy beneficial for surgical stage I ovarian clear cell carcinoma?Liat Hogen, Harry Brar, Allan Covens, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 14, 2021
Risk of second malignancy in patients with ovarian clear cell carcinomaJulie My Van Nguyen, Danielle Vicus, Sharon Nofech-Mozes, et al.
Pageof 13

Showing results (21-30 of 126) with videos related to

Sort By:
Pageof 13
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 21, 2012
Prognostic and predictive value of CA-125 in the primary treatment of epithelial ovarian cancer: potentials and pitfallsIván Díaz-Padilla, Albiruni Ryan Abdul Razak, Lucas Minig, et al.
Journal of Surgical Oncology|November 24, 2025
Treatment Strategy and Residual Disease as Determinants of Survival in Stage IVB High-Grade Serous Ovarian Cancer: A Retrospective Cohort StudyAnouk Benseler, Adina Tanen, Taymaa May, et al.
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC|May 11, 2013
A triage assessment strategy for the management of women with endometrial cancerLuc R C W van Lonkhuijzen, Barry P Rosen, Stephanie Bertin, et al.
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC|January 7, 2021
Does Radical Hysterectomy for Clinically Apparent Stage II Endometrial Cancer Affect Risk of Local Recurrence?Genevieve K Lennox, Mitchell Clark, Tiffany Zigras, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 2011
Phenotypic heterogeneity and instability of human ovarian tumor-initiating cellsJocelyn M Stewart, Patricia A Shaw, Craig Gedye, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|November 3, 2017
The prognostic value of perioperative, pre-systemic therapy CA125 levels in patients with high-grade serous ovarian cancerTaymaa May, Jocelyn M Stewart, Marcus Q Bernardini, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 29, 2022
Oncologic and pregnancy outcomes after fertility-sparing surgery for stage I, low-grade endometrioid ovarian cancerBrenna E Swift, Allan Covens, Victoria Mintsopoulos, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 31, 2021
The effect of complete surgical staging and adjuvant chemotherapy on survival in stage I, grade 1 and 2 endometrioid ovarian carcinomaBrenna E Swift, Allan Covens, Victoria Mintsopoulos, et al.
Gynecologic Oncology|August 2, 2017
Is adjuvant chemotherapy beneficial for surgical stage I ovarian clear cell carcinoma?Liat Hogen, Harry Brar, Allan Covens, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 14, 2021
Risk of second malignancy in patients with ovarian clear cell carcinomaJulie My Van Nguyen, Danielle Vicus, Sharon Nofech-Mozes, et al.
Pageof 13